fadrozole has been researched along with letrozole in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (50.00) | 18.2507 |
| 2000's | 10 (35.71) | 29.6817 |
| 2010's | 3 (10.71) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Muftuoglu, Y; Mustata, G | 1 |
| Cushman, M; Kondratyuk, TP; Marler, L; Mayhoub, AS; Park, EJ; Pezzuto, JM | 1 |
| Hartmann, RW; Hu, Q; Yin, L | 1 |
| Chen, JZ; Khan, MZI; Nazli, A; Uzair, M | 1 |
| Borja, J; Pérez, N | 1 |
| Beh, I; Bhatnagar, AS; Müller, P; Schenkel, L; Schieweck, K; Trunet, PF | 1 |
| Bhatnagar, AS; Bowman, R; Häusler, A; Lang, M; Schieweck, K | 1 |
| Brodie, A; Savinov, A; Wang, J; Yue, W | 1 |
| Bergeron, JM; Crews, D | 1 |
| Demers, LM | 1 |
| Manni, A | 1 |
| Batzl, C; Bhatnagar, AS; Bowman, R; Furet, P; Häusler, A; Lang, M | 1 |
| Crews, D; Wennstrom, KL | 1 |
| Bhatnagar, S; Krishnamurthy, H; Krishnamurthy, HN; Moudgal, RN; Shetty, G | 1 |
| Norton, A; Smith, IE | 1 |
| Bershteĭn, LM; Larionov, AA; Poroshina, TE; Zimarina, TS | 1 |
| Dowsett, M | 1 |
| Smith, IE | 1 |
| Sonoo, H | 1 |
| Auvray, P; Bichat, F; Genne, P | 1 |
| de Crémoux, P | 1 |
| Buzdar, A; Howell, A | 1 |
| Buzdar, AU | 1 |
| Adachi, I; Ikeda, T; Ohashi, Y; Sasaki, Y; Suwa, T; Tabei, T; Takatsuka, Y; Toi, M; Tominaga, T | 1 |
| Hori, H; Kagawa, N; Waterman, MR; Yoshioka, S | 1 |
| Bria, E; Carlini, P; Cognetti, F; Di Cosimo, S; Fabi, A; Felici, A; Ferretti, G; Giannarelli, D; Milella, M; Mottolese, M; Nisticò, C; Papaldo, P; Ruggeri, EM; Terzoli, E | 1 |
| Ioannidis, JP; Mauri, D; Pavlidis, N; Polyzos, NP | 1 |
| Dutta, U; Pant, K | 1 |
15 review(s) available for fadrozole and letrozole
| Article | Year |
|---|---|
An overview on Estrogen receptors signaling and its ligands in breast cancer.
Topics: Breast Neoplasms; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Humans; Ligands; Male; Receptors, Estrogen | 2022 |
Aromatase inhibitors: clinical pharmacology and therapeutic implications in breast cancer.
Topics: Aminoglutethimide; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Imidazoles; Letrozole; Nitriles; Triazoles | 1992 |
Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aromatase Inhibitors; Estrogen Antagonists; Estrogens; Fadrozole; Imidazoles; Letrozole; Mammary Neoplasms, Experimental; Nitriles; Steroids; Triazoles | 1990 |
Clinical use of aromatase inhibitors in the treatment of breast cancers.
Topics: Aminoglutethimide; Animals; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Letrozole; Nitriles; Rats; Triazoles | 1993 |
Fadrozole and letrozole in advanced breast cancer: clinical and biochemical effects.
Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Fadrozole; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Randomized Controlled Trials as Topic; Triazoles | 1998 |
Drug and hormone interactions of aromatase inhibitors.
Topics: Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Drug Interactions; Enzyme Inhibitors; Estrogens; Fadrozole; Female; Humans; Letrozole; Male; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Premenopause; Sensitivity and Specificity; Tamoxifen; Triazoles | 1999 |
Aromatase inhibitors: a dose-response effect?
Topics: Aminoglutethimide; Anastrozole; Animals; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estrogens; Fadrozole; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Triazoles | 1999 |
[Aromatase inhibitors for treatment of advanced breast cancers].
Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Estrogen Antagonists; Fadrozole; Female; Humans; Letrozole; Nitriles; Treatment Outcome; Triazoles | 2000 |
[Preclinical evaluation of aromatase inhibitors antitumor activity].
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fadrozole; Female; Humans; Letrozole; Models, Animal; Nitriles; Rats; Structure-Activity Relationship; Triazoles | 2000 |
[Aromatase inhibitors: pharmacological aspects].
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Enzyme Inhibitors; Fadrozole; Female; Humans; Letrozole; Nitriles; Triazoles | 2000 |
Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer.
Topics: Anastrozole; Androstadienes; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Fadrozole; Female; Headache; Humans; Letrozole; Nausea; Nitriles; Treatment Outcome; Triazoles; Vomiting | 2001 |
A summary of second-line randomized studies of aromatase inhibitors.
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Drug Tolerance; Enzyme Inhibitors; Estrogen Receptor Modulators; Fadrozole; Female; Humans; Letrozole; Megestrol Acetate; Neoplasms, Hormone-Dependent; Nitriles; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles | 2001 |
New aromatase inhibitors as second-line endocrine therapy in postmenopausal patients with metastatic breast carcinoma: a pooled analysis of the randomized trials.
Topics: Aged; Anastrozole; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Clinical Trials, Phase III as Topic; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Fadrozole; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Probability; Prognosis; Remission Induction; Risk Assessment; Survival Analysis; Triazoles | 2005 |
Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.
Topics: Adult; Aged; Aminoglutethimide; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Odds Ratio; Randomized Controlled Trials as Topic; Survival Analysis; Triazoles | 2006 |
Aromatase inhibitors: past, present and future in breast cancer therapy.
Topics: Aminoglutethimide; Androstadienes; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Fadrozole; Female; Humans; Letrozole; Nitriles; Triazoles | 2008 |
2 trial(s) available for fadrozole and letrozole
| Article | Year |
|---|---|
Effects of Fadrozole (CGS 16949A) and Letrozole (CGS 20267) on the inhibition of aromatase activity in breast cancer patients.
Topics: Aromatase Inhibitors; Breast Neoplasms; Estradiol; Estrogens; Estrone; Fadrozole; Female; Humans; Letrozole; Middle Aged; Nitriles; Radioimmunoassay; Triazoles | 1994 |
Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer.
Topics: Administration, Oral; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Double-Blind Method; Enzyme Inhibitors; Estradiol; Estrone; Fadrozole; Female; Humans; Letrozole; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Safety; Survival Rate; Triazoles | 2003 |
11 other study(ies) available for fadrozole and letrozole
| Article | Year |
|---|---|
Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19).
Topics: Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Binding Sites; Breast Neoplasms; Computer Simulation; Drug Design; Female; Humans; Models, Chemical; Models, Molecular; Structure-Activity Relationship | 2010 |
Optimization of the aromatase inhibitory activities of pyridylthiazole analogues of resveratrol.
Topics: Aromatase; Aromatase Inhibitors; Binding Sites; Catalytic Domain; Computer Simulation; Enzyme Assays; Humans; Resveratrol; Stilbenes; Structure-Activity Relationship; Thiazoles | 2012 |
Tetrahydropyrroloquinolinone type dual inhibitors of aromatase/aldosterone synthase as a novel strategy for breast cancer patients with elevated cardiovascular risks.
Topics: Aromatase Inhibitors; Breast Neoplasms; Cardiovascular Diseases; Cytochrome P-450 CYP11B2; Female; Humans; Magnetic Resonance Spectroscopy; Models, Molecular; Quinolones; Risk Factors; Spectrometry, Mass, Electrospray Ionization | 2013 |
Inhibition of estrogen biosynthesis and its consequences on gonadotrophin secretion in the male.
Topics: Animals; Aromatase Inhibitors; Estradiol; Estrogen Antagonists; Fadrozole; Follicle Stimulating Hormone; Humans; Imidazoles; Letrozole; Luteinizing Hormone; Male; Nitriles; Organ Size; Rats; Reference Values; Testosterone; Triazoles | 1992 |
Effect of aromatase inhibitors on growth of mammary tumors in a nude mouse model.
Topics: Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Cell Division; Fadrozole; Female; Letrozole; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Organ Size; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Triazoles; Uterus | 1995 |
Role of reductase and aromatase in sex determination in the red-eared slider (Trachemys scripta), a turtle with temperature-dependent sex determination.
Topics: Animals; Aromatase; Aromatase Inhibitors; Azasteroids; Dihydrotestosterone; Dose-Response Relationship, Drug; Fadrozole; Female; Finasteride; Letrozole; Male; Nitriles; Oxidoreductases; Sex Determination Analysis; Sex Ratio; Temperature; Testosterone; Triazoles; Turtles | 1994 |
Structure-activity relationships and binding model of novel aromatase inhibitors.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aromatase Inhibitors; Fadrozole; Female; Humans; Letrozole; Microsomes; Models, Molecular; Molecular Structure; Nitriles; Placenta; Pregnancy; Structure-Activity Relationship; Tetrazoles; Triazoles | 1993 |
Making males from females: the effects of aromatase inhibitors on a parthenogenetic species of whiptail lizard.
Topics: Animals; Aromatase Inhibitors; Enzyme Inhibitors; Fadrozole; Female; Letrozole; Lizards; Male; Nitriles; Parthenogenesis; Sex Determination Analysis; Sex Differentiation; Triazoles | 1995 |
Effect of estrogen deprivation on the reproductive physiology of male and female primates.
Topics: Animals; Aromatase; Aromatase Inhibitors; Enzyme Inhibitors; Estrogen Antagonists; Estrogens; Fadrozole; Female; Letrozole; Macaca radiata; Male; Nitriles; Pregnancy; Reproduction; Triazoles | 1997 |
[Metabolism of the androgenic precursor androstenedione and effects of aromatase inhibitors in cultured blood lymphocytes].
Topics: Adolescent; Adult; Age Factors; Aged; Androstenedione; Aromatase Inhibitors; Bucladesine; Cells, Cultured; Dexamethasone; Enzyme Inhibitors; Fadrozole; Female; Humans; Letrozole; Lymphocytes; Middle Aged; Nitriles; Triazoles | 1998 |
Characterization of stable human aromatase expressed in E. coli.
Topics: Amino Acid Sequence; Androstenedione; Arginine; Aromatase; Aromatase Inhibitors; Cell Membrane; Chaperonin 10; Chaperonin 60; Chloramphenicol; Cysteine; Electron Spin Resonance Spectroscopy; Enzyme Stability; Escherichia coli; Estradiol; Estrone; Fadrozole; Gene Expression; Humans; Letrozole; Molecular Sequence Data; Nitriles; Polymorphism, Genetic; Protein Structure, Secondary; Protein Synthesis Inhibitors; Recombinant Proteins; Solubility; Testosterone; Triazoles | 2004 |